
A portable ultrasound system could make reliable breast imaging more accessible
To make earlier diagnosis easier, an MIT team has developed portable detectors based on ultrasound, which could be used much more frequently.

To make earlier diagnosis easier, an MIT team has developed portable detectors based on ultrasound, which could be used much more frequently.

Small loops of genetic material may be strong indicators of imminent Alzheimer’s disease (AD) symptoms. In a new study published in Nature Medicine, researchers showed that elevated levels of certain circular RNAs (circRNAs) in the blood nearly tripled patients’ risk of developing symptoms, suggesting these molecules are more sensitive to symptom onset than traditional AD biomarkers.

SINGAPORE, July 1, 2026 /PRNewswire/ — NICE Surgical Solutions Pte Ltd (“NICE Surgical”), a clinical-stage medical device company pioneering full intracorporeal anastomosis surgical instruments has been officially granted the U.S. Patent No. 12,653,527 B2, for its purse-string stapler.

SkylineDX’s test stratifies cutaneous melanoma patients into metastatic risk categories to inform treatment decisions.

The comprehensive review in which this discovery was first made is published in Nature Reviews Bioengineering and was led by Giacomo Valle, assistant professor at Chalmers University of Technology in Sweden.

A collaborative research team led by National Yang Ming Chiao Tung University and National Taiwan University investigated the therapeutic potential of gene therapy administered after birth.

In a new study published in Cell Stem Cell, the researchers developed a patient-derived organoid platform to uncover how chronic pancreatitis develops at the molecular level and identify possible therapeutic strategies.

In the new study, the researchers show that METTL3 in breast cancer cells relocates from its usual location in the nucleus to the cytoplasm.

Researchers report encouraging early results from a first-in-human clinical trial led by Children’s National Hospital using a new T-cell immunotherapy for children and young adults with some of the deadliest brain tumors.

Biomedical engineers at Duke University have used induced pluripotent stem cells (iPSCs) to grow specialized blood vessel cells critical to retinal health for the first time.